SUPPORTS SCIENTIFIC COLLABORATION FOR GRANTS THAT SPAN MULTIPLE SITES
Drug Discovery Technology Conference, Boston, August 9, 2004 – Ingenuity announced today the Ingenuity Workgroup Collaboration application that will improve NIH grantees’ collaborative research efforts and other non-profit sponsored research programs. Currently in development, Ingenuity is now accepting applications for its upcoming beta program. The software will be licensed separately from IPA to non-profit institutions, and is expected to be available in Q4 of this year. Pricing has not been announced.
Ingenuity also announced today a new Ingenuity Enterprise Collaboration application for Pharmaceutical and Biotechnology Companies; a new summer ’04 release of IPA; an ROI Analysis Report from IDC Life Science Insights on large scale deployment of pathways software in pharmaceutical companies; a new, multi-year agreement with Millennium Pharmaceuticals; and the launch of Ingenuity University with inaugural class offerings that teach best practices and use of pathways analysis in life science research. For details on these other announcements, please reference the company’s other press releases dated today.
“With NIH’s increasing emphasis on grants spanning multiple research institutions, meaningful scientific collaboration has a new wrinkle to it,” stated Ron Davis, Professor and Director of Stanford Genome Technology Center. “Ingenuity’s upcoming Workgroup Collaboration application is targeted at smoothing and improving these important cross organization collaborations.”
Key features of the Ingenuity Enterprise Collaboration application are:
- Shared Spaces
- Allows a scientist to create a shared space, and identify and invite collaborators to participate in the analysis of experimental results placed within these “spaces.” Each collaborator has full-featured analysis capabilities.
- Enables scientists to add their own insights and interpretations to a colleague’s shared analysis and instantly share these insights with each other. Different types of data (text, graphics) are supported as well as multiple categories of annotations such as notes and commentary and, importantly, new computable molecular interactions that reflect proprietary knowledge not found in the public domain. Now both public and proprietary biological insights are combined for better analysis.
- These new enterprise-wide capabilities seamlessly integrate with IPA, a web-delivered application. This means that large, multi-national companies, and their external collaboration partners, can instantly enable broad collaboration for all IPA users with no infrastructure changes or installation of new software.
Ingenuity’s novel approach to improving scientific collaboration is to integrate this capability directly within the scientists’ workflow while analyzing experimental results, in contrast to other approaches typified by technologies such as shared electronic whiteboards that are not tightly integrated within the experimental results analysis workflow and require the collaborators to ‘step out’ of the analysis workflow and ‘step into’ the collaboration workflow. Integrating analysis and collaboration into a single application encourages improved collaboration.
Non-profit research institutes interested in participating in the upcoming beta program for the Ingenuity Workgroup Collaboration application should contact their sales representative or call Ingenuity at 650.967.7777.
About Ingenuity Systems
Ingenuity Systems is helping life science researchers explore and understand biological systems that are foundational to human health and disease. Ingenuity delivers capabilities and expertise to researchers through analysis software, genome-scale computable network databases, and knowledge management services and infrastructure, resulting in increased productivity and faster drugs to market. The company was founded in 1998 and is headquartered in Mountain View, California.www.ingenuity.com.